Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • National Oxygen
Join Channel
Consolidated Standalone

National Oxygen

₹161.9 -0.8 | 0.5%

Market Cap ₹82 Cr.

Stock P/E -27.0

P/B -399.5

Current Price ₹161.9

Book Value ₹ -0.4

Face Value 10

52W High ₹184.9

Dividend Yield 0%

52W Low ₹ 80.5

Edit Ratio

National Oxygen Research see more...

Overview Inc. Year: 1974Industry: Industrial Gases & Fuels

National Oxygen Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

National Oxygen Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 13 13 12 12 11 12 12 11 12 11
Other Income 1 0 0 0 0 0 0 0 0 0
Total Income 15 13 12 13 11 12 12 11 12 11
Total Expenditure 9 10 10 11 10 12 11 11 11 11
Operating Profit 6 3 2 2 1 0 1 1 1 0
Interest 1 1 1 0 0 1 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 4 2 1 1 0 -1 -0 -1 -1 -1
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 4 2 1 1 0 -1 -0 -1 -1 -1
Adjustments -0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 4 2 1 1 0 -1 -0 -1 -1 -1
Adjusted Earnings Per Share 8.4 4 1.4 2 0 -2.4 -1 -1.2 -1.3 -2.5

National Oxygen Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 25 26 28 33 36 41 46 44 40 51 47 46
Other Income 1 0 0 0 0 1 0 0 0 1 1 0
Total Income 25 26 28 34 36 42 46 44 40 52 48 46
Total Expenditure 20 26 30 30 31 36 38 38 34 39 43 44
Operating Profit 6 -0 -1 3 5 6 9 7 7 13 4 3
Interest 1 4 5 6 6 6 5 5 4 2 2 0
Depreciation 3 4 4 4 4 4 4 3 3 3 3 4
Exceptional Income / Expenses 0 0 0 0 0 2 3 0 0 0 0 0
Profit Before Tax 1 -8 -11 -7 -5 -2 4 -2 -1 8 -1 -3
Provision for Tax 0 -2 -0 -1 0 -0 0 0 0 0 0 0
Profit After Tax 1 -5 -11 -6 -5 -2 4 -2 -1 8 -1 -3
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 -5 -11 -6 -5 -2 4 -2 -1 8 -1 -3
Adjusted Earnings Per Share 1.2 -10.9 -22.6 -11.8 -10.5 -3.9 7.4 -3.3 -2.3 15.9 -1.6 -6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -8% 2% 3% 7%
Operating Profit CAGR -69% -17% -8% -4%
PAT CAGR -113% 0% 0% NAN%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 88% 39% 36% 15%
ROE Average 0% 115% 69% 5%
ROCE Average 3% 15% 16% 7%

National Oxygen Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 23 18 6 0 -5 -9 -5 -7 4 0 -1
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 22 26 30 37 38 35 30 33 19 30 27
Other Non-Current Liabilities 5 3 3 1 1 1 1 2 2 2 2
Total Current Liabilities 11 16 18 17 16 14 12 11 11 7 7
Total Liabilities 61 63 57 56 51 42 39 38 36 40 35
Fixed Assets 31 53 49 45 41 35 32 29 26 24 22
Other Non-Current Assets 23 1 2 2 2 1 1 1 1 1 2
Total Current Assets 8 9 7 8 8 6 7 8 9 14 11
Total Assets 61 63 57 56 51 42 39 38 36 40 35

National Oxygen Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 2 1 1 1 1 1 1 1 1 1 6
Cash Flow from Operating Activities 6 -2 1 1 5 8 8 5 7 12 2
Cash Flow from Investing Activities -26 -4 -2 -0 1 3 3 -0 -1 0 -1
Cash Flow from Financing Activities 18 7 0 -1 -6 -11 -11 -4 -6 -7 -6
Net Cash Inflow / Outflow -2 0 0 0 -0 0 0 0 -0 5 -4
Closing Cash & Cash Equivalent 1 1 1 1 1 1 1 1 1 6 2

National Oxygen Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 1.23 -10.95 -22.55 -11.84 -10.49 -3.89 7.42 -3.26 -2.28 15.88 -1.65
CEPS(Rs) 8.46 -2.9 -13.86 -3.63 -2.6 3.99 14.78 3.85 4.55 22.33 5.16
DPS(Rs) 1 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 47.49 36.54 12.78 0.94 -9.55 -17.71 -10.28 -13.61 9.15 0.03 -1.94
Core EBITDA Margin(%) 18.54 -1 -4.91 7.74 12.41 12.99 18.56 14.56 15.54 22.59 7.81
EBIT Margin(%) 7.63 -14.47 -17.9 -2.15 3.62 9.51 18.32 7.4 8.52 19.32 2.12
Pre Tax Margin(%) 2.19 -27.22 -35.51 -18.95 -12.8 -4.44 7.72 -3.53 -2.75 15.07 -1.68
PAT Margin (%) 2.19 -18.8 -35.15 -15.66 -12.8 -4.42 7.71 -3.56 -2.75 15.07 -1.68
Cash Profit Margin (%) 15.12 -4.98 -21.6 -4.8 -3.18 4.54 15.36 4.21 5.5 21.19 5.26
ROA(%) 1.19 -8.49 -18.07 -10.04 -9.42 -4.02 8.79 -4.04 -2.95 20.13 -2.12
ROE(%) 3.17 -26.05 -91.45 -172.53 0 0 0 0 0 346 0
ROCE(%) 5.18 -7.74 -10.55 -1.59 3.05 10.06 24.65 9.97 10.99 31.32 3.3
Receivable days 45.61 52.42 47.45 48.47 52.57 38.96 31.41 37.89 45.45 36.22 40.22
Inventory Days 5.3 7.49 7.49 6.09 4.42 2.22 1.9 3 5 5.49 7.79
Payable days 1042.48 1856.45 1334.76 962.53 1179.93 909.07 1300.68 1228.81 649.47 1451.9 2779.47
PER(x) 33.43 0 0 0 0 0 4.76 0 0 5.35 0
Price/Book(x) 0.86 1.02 3.76 43.72 -4.17 -2.21 -3.43 -2.17 4.09 2585.04 -44.55
Dividend Yield(%) 2.44 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 1.85 2.12 2.33 2.03 1.87 1.5 1.17 1.18 1.06 1.33 1.45
EV/Core EBITDA(x) 8.25 -302.93 -48.82 21.3 12.97 10.17 6.11 7.76 6.32 5.22 15.97
Net Sales Growth(%) 14.49 4.85 9.03 17.93 8.78 14.61 11.72 -4.92 -9.49 27.27 -6.9
EBIT Growth(%) -29.37 -297.18 -36.38 85.85 282.47 182.43 110.52 -61.59 4.21 188.56 -89.76
PAT Growth(%) -25.21 -992.61 -106.03 47.51 11.37 62.89 290.56 -143.93 30.02 796.44 -110.37
EPS Growth(%) -52.38 -992.61 -106.03 47.51 11.37 62.89 290.56 -143.93 30.02 796.43 -110.37
Debt/Equity(x) 1.17 2.14 7.06 106.95 -10.69 -5.18 -7.72 -5.9 5.74 2077.23 -30.89
Current Ratio(x) 0.72 0.54 0.37 0.51 0.49 0.41 0.55 0.78 0.8 1.93 1.51
Quick Ratio(x) 0.68 0.5 0.34 0.47 0.47 0.4 0.53 0.74 0.74 1.81 1.35
Interest Cover(x) 1.4 -1.13 -1.02 -0.13 0.22 0.68 1.73 0.68 0.76 4.55 0.56
Total Debt/Mcap(x) 1.35 2.09 1.88 2.45 2.56 2.35 2.25 2.72 1.4 0.8 0.69

National Oxygen Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 69.99 69.99 69.99 69.99 69.99 69.99 69.99 69.99 69.99 69.99
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at -399.5 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 115%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Debtor days have increased from 1451.9 to 2779.47days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

National Oxygen News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!